Stay updated on Nivolumab Combo in Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.

Latest updates to the Nivolumab Combo in Smoldering Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.6.5 has been added, replacing Revision: v3.6.4 to indicate a platform update.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a minor site revision. There is no evidence of changes to the study details on the page.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a newer version of the page or its metadata. This change does not modify substantive content.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page shows a revision update from v3.6.0 to v3.6.2, reflecting a backend/template change with no evident changes to the study details.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page now indicates that no participants are being sought, signaling that recruitment is closed. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment heading formatting was refined, accompanied by a Revision: v3.6.0 note.SummaryDifference0.4%

- Check78 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the ClinicalTrials.gov page.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Combo in Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.